Your browser doesn't support javascript.
loading
SARS-CoV-2 Seroconversion and Pregnancy Outcomes in a Population of Pregnant Women Recruited in Milan, Italy, between April 2020 and October 2020.
Accurti, Veronica; Gambitta, Bianca; Iodice, Simona; Manenti, Alessandro; Boito, Simona; Dapporto, Francesca; Leonardi, Margherita; Molesti, Eleonora; Fabietti, Isabella; Montomoli, Emanuele; Bollati, Valentina; Persico, Nicola.
Afiliación
  • Accurti V; Fetal Medicine and Surgery Service, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Gambitta B; Fetal Medicine and Surgery Service, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Iodice S; EPIGET Lab, Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
  • Manenti A; VisMederi Srl, 53100 Siena, Italy.
  • Boito S; Fetal Medicine and Surgery Service, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Dapporto F; VisMederi Srl, 53100 Siena, Italy.
  • Leonardi M; VisMederi Srl, 53100 Siena, Italy.
  • Molesti E; VisMederi Srl, 53100 Siena, Italy.
  • Fabietti I; Fetal Medicine and Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
  • Montomoli E; VisMederi Srl, 53100 Siena, Italy.
  • Bollati V; Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.
  • Persico N; EPIGET Lab, Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
Article en En | MEDLINE | ID: mdl-36554602
ABSTRACT
The possible link between SARS-CoV-2 infection and adverse pregnancy outcomes has so far demonstrated heterogeneous results in terms of maternal, fetal, and neonatal complications. We aim to investigate the correlation between SARS-CoV-2 seroconversion and/or neutralization titer and pregnancy outcomes. We analyzed a population of 528 pregnant women followed up from the first trimester of gestation until delivery. For each woman, we collected a first blood sample between 11 and 13 weeks of gestation and a second sample in the perinatal period (between peripartum and puerperium) to assess the presence of SARS-CoV-2 antibodies and/or microneutralization titer (MN titer). Data on pregnancy outcomes (gestational age at delivery, preterm birth before 34 weeks, hypertensive disorders, gestational diabetes, and abnormal fetal growth) were collected. We observed that serologic status per se is not associated with major pregnancy complications. On the contrary, the MN titer was associated with increased odds of gestational diabetes. Although we mainly reported asymptomatic SARS-CoV-2 infections and the absence of severe maternal and neonatal adverse outcomes, SARS-CoV-2 infection might challenge the maternal immune system and explain the moderate increase in adverse outcome odds.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Complicaciones Infecciosas del Embarazo / Diabetes Gestacional / Nacimiento Prematuro / COVID-19 Límite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Int J Environ Res Public Health Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Complicaciones Infecciosas del Embarazo / Diabetes Gestacional / Nacimiento Prematuro / COVID-19 Límite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Int J Environ Res Public Health Año: 2022 Tipo del documento: Article País de afiliación: Italia